From the historical data no, but with modern techniques yes. This question will be an explorative aim in all our future trials. Having said this Bisantrene seems to work in cancers with quite a wide range of different mutations so it is possible that there is not specific cancer type that responds best.
-
- There are more pages in this discussion • 2,801 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
-0.080(6.23%) |
Mkt cap ! $210.2M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.29 | $1.21 | $133.4K | 106.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7933 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.23 | 4631 | 1 |
View Market Depth
| Last trade - 11.21am 24/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |